In The News,
Marc Samuels and Lindsay Bealor Greenleaf quoted in BioPharma Dive
Marc Samuels and Director Lindsay Bealor Greenleaf are quoted in BioPharma Dive
Written By Judy Packer-Tursman
Monday, 27 February 2017
ADVI CEO Marc Samuels and Director Lindsay Bealor Greenleaf are quoted in BioPharma Dive’s look at why drug pricing seems so complicated. Both outline a roadmap for successful pricing strategy.